Eighteen researchers call for a temporary stop to all clinical uses of human germline editing in a piece appearing in Nature.
The company hopes to commercialize the assay, and is pursuing a larger validation study, but may face competitors who have also staked claims for this indication.
Epigenomics terminated a licensing contract related to Chinese distribution rights for its Septin9 biomarker and Epi proColon colorectal cancer blood test.
In Nucleic Acids Research this week: characterization of imprinted DNA methylation sites, origins of germline structural variants, and more.
Researchers brought together blood transcriptomic, metabolomic, proteomic, and immune cell profiles for dozens of West African and Australasian infants.
Singapore-based Lucence Diagnostics will team with Stanford to analyze sequencing and imaging of liver cancer patients to predict therapeutic effectiveness.
Researchers in Japan have transferred woolly mammoth nuclei into mice ova, where they appeared to somewhat function, according to the Telegraph.
In PNAS this week: differential gene expression predictor, clonal evolution dynamics in colorectal cancer, and more.
With retrospective and prospective analyses on women with BRCA1/2 mutations, investigators began teasing out breast cancer risk relative to reproductive history.
The South China Morning Post reports that China is encouraging its private sector to increase its investment in basic research.
Researchers tie a variant in ADAMTS3 to breathing difficulties in dissimilar dog breeds, according to Discover's D-brief blog.
The Japan Times reports that researchers sequenced the genome of a woman who lived during the Jomon period.
Parents of children with rare genetic disease have to contend with shifts in the interpretation of genetic variants, the Wall Street Journal reports.
In Science this week: single-nucleus RNA sequencing of brain tissue from individuals with autism, and more.